With rare exceptions, biotechnology and pharmaceutical companies validate their business plans through clinical trials, results from which are often presented and dissected at medical conferences throughout the year. These are the forums where executives get to showcase the “proof of concept' they so frequently talk about..

除极少数例外，生物技术和制药公司通过临床试验来验证其商业计划，临床试验的结果经常在全年的医学会议上呈现和剖析。在这些论坛上，高管们可以展示他们经常谈论的“概念验证”。。

Some meetings tend to spotlight the early human research that first indicates a new treatment’s potential. Others are for the late-stage study findings that can pave the way toward regulatory approval.

一些会议倾向于关注早期的人类研究，这些研究首先表明了一种新疗法的潜力。其他人则支持后期研究结果，这可以为监管部门的批准铺平道路。

Below, BioPharma Dive has collected schedules for the key medical meetings remaining in 2024 and planned in 2025, as well as for a few key industry events.

下面，BioPharma Dive收集了2024年剩余并计划于2025年举行的关键医疗会议以及一些关键行业活动的时间表。

Top medical and industry meetings in 2024 and 2025

2024年和2025年的顶级医疗和行业会议

17th Clinical Trials on Alzheimer's Disease

第17次阿尔茨海默病临床试验

Oct. 29 - Nov. 1, 2024

2024年10月29日-11月1日

Madrid

马德里

Focused on medicines for Alzheimer’s disease, CTAD hosts researchers and experts in the field to discuss new treatment approaches for the neurological condition. Typically, these discussions concern clinical research, but the conference now has two recently approved drugs to spotlight: Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla..

CTAD专注于治疗阿尔茨海默病的药物，邀请该领域的研究人员和专家讨论神经系统疾病的新治疗方法。通常，这些讨论涉及临床研究，但会议现在有两种最近批准的药物值得关注：卫材和Biogen的Leqembi和礼来的Kisulla。。

The Liver Meeting

肝脏会议

Nov. 15 - 19, 2024

2024年11月15日至19日

San Diego

圣地亚哥

Thousands of hepatology professionals gather each year at the American Association for the Study of Liver Diseases’ annual meeting. The 75th iteration will host courses, lectures and workshops discussing various topics surrounding liver diseases including pediatrics, clinical trial design and the use of GLP-1s as potential treatments..

每年有数千名肝病学专业人士聚集在美国肝病研究协会年会上。第75次迭代将举办课程、讲座和研讨会，讨论围绕肝病的各种主题，包括儿科、临床试验设计和使用GLP-1作为潜在治疗方法。。

American Heart Association Scientific Sessions

美国心脏协会科学会议

Nov. 16 - 18, 2024

2024年11月16日至18日

Chicago

芝加哥

AHA is always a major forum for the latest research on medicines to treat diseases of the heart. In 2024, the meeting will spotlight, among other things, the so-called GLP-1 agonists that have shown great promise at curbing heart risk. A featured session on Nov. 17 will discuss the drugs and what AHA is calling a “new frontier in cardiovascular therapeutics.”.

AHA一直是治疗心脏疾病药物最新研究的主要论坛。2024年，会议将重点关注所谓的GLP-1激动剂，这些激动剂在控制心脏病风险方面显示出巨大的前景。11月17日的专题会议将讨论这些药物以及AHA所称的“心血管治疗的新前沿”。

American Society of Hematology Annual Meeting

美国血液学会年会

Dec. 7 - 10, 2024

2024年12月7日至10日

San Diego

圣地亚哥

In 2023, ASH’s annual meeting coincided with the U.S. approval of two gene therapies for sickle cell disease. 2024’s conference may not have as dramatic an introduction, but is just as likely to feature compelling new research on treatments for diseases of the blood.

2023年，ASH的年会恰逢美国批准镰状细胞病的两种基因疗法。。

J.P. Morgan Healthcare Conference

J、 摩根大通医疗会议

TBD

TBD

San Francisco

旧金山

Every year, biopharma investors and executives descend on San Francisco’s Union Square to talk deals. With luck, a handful of companies will have new acquisitions or partnerships to announce during the meeting’s first few days — M&A auspices that will read closely for signs of what’s to come in the year ahead..

每年，生物制药的投资者和高管都会来到旧金山的联合广场谈论交易。幸运的是，少数几家公司将在会议的头几天宣布新的收购或合作伙伴关系-并购赞助将仔细阅读未来一年的迹象。。

BIO CEO and Investor Conference

生物科技首席执行官和投资者会议

Feb. 10 - 11, 2025

2025年2月10日-11日

New York

纽约

Fittingly for a conference hosted in New York, BIO CEO has an investor focus. Panels and fireside chats with industry leaders fill the agenda, but the meeting is also the site of thousands of partnering meetings between attendees, according to the organizer.

BIO首席执行官以投资者为中心，非常适合在纽约举行的会议。据主办方介绍，与行业领袖的座谈会和炉边聊天充满了议程，但会议也是与会者之间数千次合作会议的场所。

American College of Cardiology Annual Scientific Session

美国心脏病学会年度科学会议

March 29 - 31, 2025

2025年3月29日至31日

Chicago

芝加哥

The growing body of evidence showing that treating obesity reduces heart-related complications is turning discussions at cardiology meetings from narrow examinations of biomarkers like cholesterol to broader debates about metabolic risk. With numerous clinical trials generating data in obesity, ACC is likely to feature presentations that help inform the field’s direction..

越来越多的证据表明，治疗肥胖可以减少与心脏相关的并发症，这将心脏病学会议上的讨论从对胆固醇等生物标志物的狭义检查转向对代谢风险的更广泛辩论。随着大量临床试验产生肥胖数据，ACC可能会提供有助于告知该领域方向的演示文稿。。

American Academy of Neurology Annual Meeting

美国神经病学学会年会

April 5 - 9, 2025

2025年4月5日至9日

San Diego

圣地亚哥

In January 2020, then Roche Pharmaceuticals CEO Bill Anderson predicted this decade would be as important for neuroscience research as the 2010s were for oncology. AAN is the forum for assessing how well his prediction is panning out, often featuring the latest findings in research for diseases like Alzheimer’s and Parkison’s..

2020年1月，时任罗氏制药首席执行官的比尔·安德森预测，这十年对神经科学研究的重要性将与2010年对肿瘤学的重要性一样。AAN是评估其预测效果的论坛，通常以阿尔茨海默氏症和帕金森氏症等疾病研究的最新发现为特色。。

American Association of Cancer Research Annual Meeting

美国癌症研究协会年会

April 25 - 30, 2025

2025年4月25日至30日

Chicago

芝加哥

While the American Society of Clinical Oncology’s meeting often gets billed as the field’s largest conference, AACR has become an equally major gathering for cancer research, particularly earlier-stage findings on new drug mechanisms of action or treatment modalities.

虽然美国临床肿瘤学会的会议经常被称为该领域最大的会议，但AACR已经成为癌症研究的重要聚会，特别是关于新药作用机制或治疗方式的早期发现。

European Association for the Study of the Liver Congress

欧洲肝脏研究协会大会

May 7 - 10, 2025

2025年5月7日至10日

Amsterdam

阿姆斯特丹

From hepatitis C to MASH, the burden of liver diseases is large and costly. Europe’s main hepatology meeting is an international forum for the latest research into these disorders as clinicians present data on risk factors and new treatment approaches.

从丙型肝炎到糖浆，肝病的负担巨大且昂贵。欧洲主要的肝病学会议是一个国际论坛，为临床医生提供有关危险因素和新治疗方法的数据，对这些疾病进行最新研究。

American Society of Gene and Cell Therapy Annual Meeting

美国基因与细胞治疗学会年会

May 13 - 17, 2025

2025年5月13日至17日

New Orleans

新奥尔良

ASGCT has grown with the cell and gene therapy field, becoming a premier conference as the sector has expanded and treatments have advanced further into human testing. While much is still promising with such therapies, the difficulties companies face in successfully marketing them have made the meeting a health check for the sector as well..

ASGCT随着细胞和基因治疗领域的发展而发展，随着该领域的扩大和治疗进一步进入人体测试，它已成为首要会议。虽然这种疗法仍有很大的前景，但公司在成功营销它们时面临的困难也使会议成为该行业的健康检查。。

American Society of Clinical Oncology Annual Meeting

美国临床肿瘤学会年会

May 30 - June 3, 2025

2025年5月30日至6月3日

Chicago

芝加哥

ASCO is a lodestone for cancer drug research with the highest profile and widest impact. The data presented each year at the McCormick Place in Chicago often changes treatment standards, as well as makes (or breaks) the fortunes of drug developers.

ASCO是用于癌症药物研究的磁石，具有最高的知名度和最广泛的影响。每年在芝加哥麦考密克广场（McCormickPlace）公布的数据经常会改变治疗标准，也会影响（或破坏）药物开发人员的财富。

BIO International Convention

生物国际公约

June 16 - 19, 2025

2025年6月16日至19日

Boston

波士顿

Always following closely on the heels of ASCO, BIO’s International Convention is a important convener for biotech and pharma companies’ business development teams. It’s also regularly a venue for industry leaders to discuss and debate the top challenges facing the sector.

生物技术国际会议始终紧随ASCO之后，是生物技术和制药公司业务开发团队的重要召集人。它也是行业领导者经常讨论和辩论该行业面临的最大挑战的场所。

American Diabetes Association 85th Scientific Session

美国糖尿病协会第85届科学会议

June 20 - 23, 2025

2025年6月20日至23日

Chicago

芝加哥

ADA is one of the largest medical meetings focused on diabetes and frequently features new research on the care and treatment of differieng patient populations with the condition.

ADA是最大的以糖尿病为主题的医学会议之一，经常推出关于护理和治疗不同患者人群的新研究。

European Society of Cardiology Annual Congress

Aug. 29 - Sept. 1, 2025

2025年8月29日至9月1日

Madrid

马德里

In 2025, ESC will be held together with the World Congress of Cardiology, a co-hosting that last occurred in 2019. The conference organizers say the collaboration will highlight how heart disease remains the world’s leading cause of death.

2025年，ESC将与世界心脏病学大会一起举行，上一次共同主办是在2019年。会议组织者表示，此次合作将突显心脏病如何仍然是世界上主要的死亡原因。

European Society of Medical Oncology Congress

Oct. 17 - 21, 2025

2025年10月17日至21日

Berlin

ESMO is Europe’s answer to ASCO and just as often features standard-shifting cancer research. While immunotherapy remains an active area of exploration for drugmakers, increasingly other treatment types like antibody-drug conjugates and radiopharmaceuticals have been featured at oncology conferences..

ESMO是欧洲对ASCO的回应，并且经常以标准转变的癌症研究为特色。虽然免疫疗法仍然是制药商积极探索的领域，但越来越多的其他治疗类型，如抗体-药物偶联物和放射性药物已在肿瘤学会议上亮相。。